Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: An economic evaluation within a randomized controlled trial

Critical Care

Volumn 14, Issue 3, 2010, Pages

  Opmeer, Brent C ^a   Boer, Kimberly R ^a   van Ruler, Oddeke ^a   Reitsma, Johannes B ^a   Gooszen, Hein G ^b   de Graaf, Peter W ^c   Lamme, Bas ^d   Gerhards, Michael F ^c   Steller, E Philip ^e   Mahler, Cecilia M ^a   Obertop, Huug ^a   Gouma, Dirk J ^a   Bossuyt, Patrick M M ^a   de Borgie, Corianne A J M ^a   Boermeester, Marja A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Reinier de Graaf Gasthuis ^*  (Netherlands)

^d GELRE HOSPITALS   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APACHE; ARTICLE; COMPARATIVE STUDY; CONVALESCENCE; DISEASE SEVERITY; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; NETHERLANDS; PERITONITIS; PLANNED RELAPAROTOMY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELAPAROTOMY ON DEMAND; REOPERATION; SENSITIVITY ANALYSIS; TEACHING HOSPITAL; ADOLESCENT; ADULT; AGED; COST; ECONOMICS; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APACHE; COSTS AND COST ANALYSIS; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; LAPAROTOMY; MIDDLE AGED; NETHERLANDS; PERITONITIS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REOPERATION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 78651257658     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9032     Document Type: Article

References (29)

1. Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH. Surgical Infection Society intra-abdominal infection study: prospective evaluation of management techniques and outcome. Arch Surg 1993, 128:193-198.
2. Koperna T, Schulz F. Prognosis and treatment of peritonitis: do we need new scoring systems?. Arch Surg 1996, 131:180-186.
3. Lamme B, Boermeester MA, Belt EJ, van Till JW, Gouma DJ, Obertop H. Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg 2004, 91:1046-1054. 10.1002/bjs.4517, 15286969.
4. Wittmann DH, Schein M, Condon RE. Management of secondary peritonitis. Ann Surg 1996, 224:10-18. 10.1097/00000658-199607000-00003, 1235241, 8678610.
5. Anaya DA, Nathens AB. Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt ) 2003, 4:355-362. 10.1089/109629603322761418, 15012862.
6. van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, . Dutch Peritonitis Study Group Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 2007, 298:865-872. 10.1001/jama.298.8.865, 17712070, Dutch Peritonitis Study Group.
7. Knaus WA, Harrell FE, Lynn J, Goldman L, Phillips RS, Connors AF, Dawson NV, Fulkerson WJ, Califf RM, Desbiens N, Layde P, Oye RK, Bellamy PE, Hakim RB, Wagner DP. The SUPPORT prognostic model: objective estimates of survival for seriously ill hospitalized adults: study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 1995, 122:191-203.
8. Bohnen JM, Mustard RA, Oxholm SE, Schouten BD. APACHE II score and abdominal sepsis: a prospective study. Arch Surg 1988, 123:225-229.
9. Gold MR, Siegel JE, Russel LB. Cost-effectiveness in Health and Medicine. 1996, New York: Oxford University Press.
10. Edbrooke D, Hibbert C, Ridley S, Long T, Dickie H. The development of a method for comparative costing of individual intensive care units: The Intensive Care Working Group on Costing. Anaesthesia 1999, 54:110-120. 10.1046/j.1365-2044.1999.00650.x, 10215705.
11. Riteco JA, Heij LJ, Luijn JC, Wolff I. Richtlijnen voor farmaco-economisch onderzoek [Guidelines for pharmaco-economic research]. 1999, Amstelveen: College voor Zorgverzekeringen (CvZ) [Health Insurance Board].
12. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002, 20:443-454. 10.2165/00019053-200220070-00002, 12093300.
13. van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF. Labor and health status in economic evaluation of health care: The Health and Labor Questionnaire. Int J Technol Assess Health Care 1996, 12:405-415.
14. Oostenbrink JB, Buijs-Van der WT, van AM, Koopmanschap MA, Rutten FF. Unit costs of inpatient hospital days. Pharmacoeconomics 2003, 21:263-271. 10.2165/00019053-200321040-00004, 12600221.
15. Van der Kuy A. Farmacotherapeutisch Kompas 2000/2001 [Pharmacotherapeutic Compass 2000/2001] 2000, Amstelveen: College voor zorgverzekeringen (CvZ) [Health Insurance Board].
16. Huiskes LG. Tarieflijst instellingen 2001 [Tariff list institutions 2001]. 2000, College Tarieven Gezondheidszorg (CTG) [National Health Tariffs Authority].
17. Roland M, Torgerson DJ. What are pragmatic trials?. BMJ 1998, 316:285. 2665488, 9472515.
18. Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S. Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report. Value Health 2005, 8:521-533. 10.1111/j.1524-4733.2005.00045.x, 16176491.
19. Koperna T. Cost-effectiveness of defunctioning stomas in low anterior resections for rectal cancer: a call for benchmarking. Arch Surg 2003, 138:1334-1338. 10.1001/archsurg.138.12.1334, 14662534.
20. Sznajder M, Aegerter P, Launois R, Merliere Y, Guidet B, CubRea. A cost-effectiveness analysis of stays in intensive care units. Intensive Care Med 2001, 27:146-153. 10.1007/s001340000760, 11280626.
21. Heyland DK, Konopad E, Noseworthy TW, Johnston R, Gafni A. Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest 1998, 114:192-198. 10.1378/chest.114.1.192, 9674469.
22. Moerer O, Schmid A, Hofmann M, Herklotz A, Reinhart K, Werdan K, Schneider H, Burchardi H. Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med 2002, 28:1440-1446. 10.1007/s00134-002-1429-9, 12373469.
23. Flaatten H, Kvale R. Cost of intensive care in a Norwegian University hospital 1997-1999. Crit Care 2003, 7:72-78. 10.1186/cc2331, 154120, 12617743.
24. Hau T, Ohmann C, Wolmershauser A, Wacha H, Yang Q. Planned relaparotomy vs relaparotomy on demand in the treatment of intra-abdominal infections: The Peritonitis Study Group of the Surgical Infection Society-Europe. Arch Surg 1995, 130:1193-1196.
25. Lamme B, Boermeester MA, Reitsma JB, Mahler CW, Obertop H, Gouma DJ. Meta-analysis of relaparotomy for secondary peritonitis. Br J Surg 2002, 89:1516-1524. 10.1046/j.1365-2168.2002.02293.x, 12445059.
26. Lamme B, Boermeester MA, de VR, van RO, van Till JW, Obertop H. Survey among surgeons on surgical treatment strategies for secondary peritonitis. Dig Surg 2003, 21:387-395. 10.1159/000081883, 15523182.
27. van Goor H, Hulsebos RG, Bleichrodt RP. Complications of planned relaparotomy in patients with severe general peritonitis. Eur J Surg 1997, 163:61-66.
28. Wacha H, Linder MM, Feldmann U, Wesch G, Gundlach E, Steifensand RA. Mannheim Peritonitis Index: prediction of risk of death from peritonitis: construction of a statistical and validation of an emperically based index. Theor Surg 1987, 2:169-177.
29. Giesbers H. Beddencapaciteit ziekenhuizen. Volksgezondheid Toekomst Verkenning, Nationale Atlas Volksgezondheid 2003, Bilthoven: RIVM.